Eosinophil inflammation in asthma

American Journal of Respiratory and Critical Care Medicine

Volumn 150, Issue 5 II, 1994, Pages

  Bousquet, Jean ^a   Chanez, Pascal ^b   Vignola, Antonio M ^b   Lacoste, Jean Yves ^b   Michel, François B ^b  

^a HÔPITAL ARNAUD DE VILLENEUVE   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ASTHMA; BRONCHUS BIOPSY; CONFERENCE PAPER; EOSINOPHIL; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOPATHOGENESIS; INFLAMMATION; LUNG FLUID; LUNG LAVAGE; PRIORITY JOURNAL; SPUTUM ANALYSIS;

EID: 0028127240     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm/150.5_pt_2.s33     Document Type: Conference Paper

References (105)

1. Bousquet J, Chanez P, Lacoste JY, Barnéon G, Ghavanian N, Enander I, Venge P, Ahlstedt S, Lafontaine J, Godard P, Michel FB. Eosinophilic inflammation in asthma. N Engl J Med 1990;323:1033-9.
2. Hakansson L, Rak S, Venge P. The formation of eosinophil and neutrophil chemotactic activity during a pollen season and after allergen challenge. J Allergy Clin Immunol 1989;83:933-9.
3. Horn BR, Robin ED, Theodore J, Van Kessel A. Total eosinophil counts in the management of bronchial asthma. N Engl J Med 1975;292: 1152-5.
4. Fukluda T, Dunnette SL, Reed CE, Ackerman SJ, Peters MS, Gleich GJ. Increased numbers of hypodense eosinophils in the blood of patients with bronchial asthma. Am Rev Respir Dis 1985;132:981-5.
5. Prin L, Capron M, Tonnel AB, Bletry O, Capron A. Heterogeneity of human peripheral blood eosinophils: variability in cell density and cytotoxic ability in relation to the level and the origin of hypereosinophilia. Int Arch Allergy Appl Immunol 1983;72:336-46.
6. Shult PA, Lega M, Jaridi S, Vrtis R, Warner T, Graziano FM, Busse WW. The presence of hypodense eosinophils and diminished chemoluminescence response in asthma. J Allergy Clin Immunol 1988;81:429-37.
7. Venge P, Dahl R, Peterson CGB. Eosinophil granule proteins in serum after allergen challenge of the asthmatic patients and the effects of anti-asthmatic medication. Int Arch Allergy Appl Immunol 1988;87: 306-12.
8. Rak S, Bjornson A, Hakanson L, Sorenson S, Venge P. The effect of immunotherapy on eosinophil accumulation and production of eosinophil chemotactic activity in the lung of subjects with asthma during natural pollen exposure. J Allergy Clin Immunol 1991;88:878-88.
9. Griffin E, Häkansson L, Formgren H, Jörgensen K, Peterson C, Venge P. Blood eosinophil number and activity in relation to lung function in patients with asthma and with eosinophilia. J Allergy Clin Immunol 1991;87:548-57.
10. Wempe JB, Tammeling EP, Koëter GH, Häkansson L, Venge P, Potsma DS. Blood eosinophil numbers and activity during 24 hours: effects of treatment with budesonide and bambuterol. J Allergy Clin Immunol 1992;90:757-65.
11. Dunhill MS. Asthma. In: Dunhill MS, ed. Pulmonary Pathology, Endiburgh: Churchill-Livingstone, 1987;61-80.
12. Moqbel R, Barkans J, Bradley BL, Durham SR, Kay AB. Application of monoclonal antibodies against major basic protein (BMK-13) and eosinophil cationic protein (EG1 and EG2) for quantifying eosinophils in bronchial biopsies from atopic asthma. Clin Exp Allergy 1992;22: 265-73.
13. Bentley AM, Menz G, Storz C, Robinson DS, Bradley B, Jeffery PK, Durham SR, Kay AB. Identification of T lymphocytes, macrophages and activated eosinophils in the bronchial mucosa of intrinsic asthma: relationship to symptoms and bronchial responsiveness. Am Rev Respir Dis 1992;145:500-5.
14. Poston R, Litchfield P, Chanez P, Lacoste JY, Lee TK, Bousquet J. Immunohistochemical characterization of the cellular infiltration of asthmatic bronchi. Am Rev Respir Dis 1992;145:918-21.
15. Djukanovic R, Wilson JW, Britten KM, Wilson SJ, Walls AF, Roche WR, Howarth PH, Holgate ST. Quantification of mast cells and eosinophils in the bronchial mucosa of symptomatic atopic asthmatics and healthy control subjects using immunohistochemistry. Am Rev Respir Dis 1990;142:863-71.
16. Jeffery PK, Wardlaw AJ, Nelson FC, Collins JV, Kay AB. Bronchial biopsies in asthma: an ultrastructural, quantitative study and correlation with hyperreactivity. Am Rev Respir Dis 1989;140:1745-53.
17. Laitinen LA, Laitinen LA, Haahtela T. Airway mucosal inflammation even in patients with newly diagnosed asthma. Am Rev Respir Dis 1992; 147:697-704.
18. Ohashi Y, Motojima S, Fukuda T, Makino S. Airway hyperresponsiveness, increased intracellular spaces of bronchial epithelium, and increased infiltration of eosinophils and lymphocytes in bronchial mucosa in asthma. Am Rev Respir Dis 1992;145:1469-76.
19. Saetta M, Di Stefano A, De Marzo N, Milani GF, Pivirotto F, Mapp CE, Fabbri LM. Airway mucosal inflammation in occupational asthma induced by toluene diisocyanate. Am Rev Respir Dis 1992;145:160-8.
20. Djukanovic R, Lai CKW, Wilson JW, Britten KM, Wilson SJ, Roche WR, Howarth PH, Holgate ST. Bronchial mucosal manifestations of atopy: a comparison of markers of inflammation between atopic asthmatics, atopic nonasthmatics and healthy controls. Eur Respir J 1992;5:538-44.
21. Kirby J, Hargreave E, Gleich G, O'Byrne P. Bronchoalveolar cell profiles of asthmatic and nonasthmatic subjects. Am Rev Respir Dis 1987;136:379-83.
22. Van Vyve T, Chanez P, Lacoste J, Bousquet J, Michel F, Godard P. Comparison between bronchial and alveolar samples of bronchoalveolar lavage fluid in asthma. Chest 1992;102:356-61.
23. Ferguson AC, Whitelaw M, Brown H. Correlation of bronchial eosinophil and mast cell activation with bronchial hyperresponsiveness in children with asthma. J Allergy Clin Immunol 1992;90:609-13.
24. Wardlaw A, Dunnette S, Gleich G, Collins J, Kay A. Eosinophils and mast cells in bronchoalveolar lavage in subjects with mild asthma: relationship to bronchial hyperreactivity. Am Rev Respir Dis 1988; 137:62-9.
25. Schmekel B, Blom-Bulow B, Hornblad Y, Laitinen LA, Linden M, Venge P. Granulocytes and their secretory products, myeloperoxidase and eosinophil cationic protein, in bronchoalveolar lavage fluids from two lung lobes in normal subjects. Eur Respir J 1991;4:867-71.
26. Poulter LW, Norris A, Power C, Condez A, Schmekel B, Burke C. T-cell dominated inflammatory reactions in the bronchi of asthmatics are not reflected in matched bronchoalveolar lavage specimens. Eur Respir J 1992;5:182-9.
27. Bousquet J, Chanez P, Lacoste J, Enander I, Venge P, Peterson C, Ahlstedt S, Michel F, Godard P. Indirect evidence of bronchial inflammation assessed by titration of inflammatory mediators in BAL fluid of patients with asthma. J Allergy Clin Immunol 1991;88:649-60.
28. Walker C, Kaegi MK, Braun P, Blaser K. Activated T cells and eosinophilia in bronchoalveolar lavages from subjects with asthma correlated with disease severity. J Allergy Clin Immunol 1991;88:935-42.
29. Bousquet J, Chanez P, Campbell AM, Enander I, Godard P, Michel FB. Monitoring of inflammatory cells in asthma. In: Miyamoto T, Okuda M, eds. Progress in Allergy and Clinical Immunology, Volume 2. Kyoto: Gottingen, Hogrefe & Huber Publishers, 1992:203-10.
30. Wardlaw A, Dunnette S, Gleich G, Collins J, Kay A. Eosinophils and mast cells in bronchoalveolar lavage in subjects with mild asthma: relationship to bronchial hyperreactivity. Am Rev Respir Dis 1988; 137:62-9.
31. Kelly C, Ward C, Stenton C, Bird G, Hendrick D, Walters E. Number and activity of inflammatory cells in bronchoalveolar lavage fluid in asthma and their relation to airway responsiveness. Thorax 1988;43: 684-92.
32. Ferguson AC, Wong FW. Bronchial hyperresponsiveness in asthmatic children: correlation with macrophages and eosinophils in broncholavage fluid. Chest 1989;96:988-91.
33. Dupuis R, Collins DS, Koh YY, Pollice M, Albertine KH, Fish JE, Peters SP. Effect of antigen dose on the recruitment of inflammatory cells to the lung by segmental antigen challenge. J Allergy Clin Immunol 1992;89:850-7.
34. Frigas E, Loegering DA, Solley GO, Frrow GM, Gleich GJ. Elevated levels of eosinophil granule major basic protein in the sputum of patients with bronchial asthma. Mayo Clin Proc 1981;56:345-52.
35. Gibson PG, Girgis-Gabardo A, Morris MM, Mattoli S, Kay JM, Dolovich J, Denburg J, Hargreave FE. Cellular characteristics of sputum from patients with asthma and chronic bronchitis. Thorax 1989;44:689-92.
36. Pin I, Gibson PG, Kolendowicz R, et al. Use of induced sputum cell counts to investigate airway inflammation in asthma. Thorax 1992;27:25-9.
37. Virchow JC, Hölscher U, Virchow C Sr. Sputum ECP levels correlate with parameters of airflow obstruction. Am Rev Respir Dis 1992;146: 604-6.
38. Bousquet J, Van Vyve T, Chanez P, Michel FB, Godard P. Cells and mediators in bronchoalveolar lavage in asthma. Eur Respir Rev 1993;(In Press).
39. Metzger W, Zavala D, Richerson H, Moseley P, Iwamota P, Monick M, Sjoerdsma K, Hunninghake W. Local allergen challenge and bronchoalveolar lavage of allergic asthmatic lungs: description of the model and local airway inflammation. Am Rev Respir Dis 1987;135:433-40.
40. De Monchy J, Kaufmann H, P PV, Koëter G, Jansen H, Sluiter H, DeVries K. Bronchoalveolar eosinophilia during allergen-induced late asthmatic reactions. Am Rev Respir Dis 1985;131:373-6.
41. Rossi G, Crimi E, Lantero S, Gianiorio P, Oddera S, Crimi P, Brusasco V. Late-phase asthmatic reaction to inhaled allergen is associated with early recruitment of eosinophils in the airways. Am Rev Respir Dis 1991;144:379-83.
42. Aalbers R, Kauffman HK, Vrugt B, Smith M, Koeter GH, Timens W, de Monchy JG. Bronchial lavage and bronchoalveolar lavage in allergen-induced single early and dual asthmatic responders. Am Rev Respir Dis 1993;147:76-81.
43. Diaz P, Gonzales M, Galleguillos F, Ancic P, Cromwell O, Shepherd D, Durham S, Gleich G, Kay A. Leukocytes and mediators in bronchoalveolar lavage during induced late-phase asthmatic reactions. Am Rev Respir Dis 1989;139:1383-9.
44. Lam S, Leriche J, Phillips D, Chan-Yeung M. Cellular and protein changes in bronchial lavage fluid after late asthmatic reaction in patients with red cedar asthma. J Allergy Clin Immunol 1987;80:44-50.
45. Fabbri L, Boschetto P, Zocca E, Milani G, Pivirotto F, Plebani M, Burlina A, Licata B, Mapp C. Bronchoalveolar neutrophilia during late asthmatic reactions induced by Toluene Diisocyanate. Am Rev Respir Dis 1987;136:36-42.
46. Aleva RM, Aalbers R, Koeter GH, De Monchy JG. Occupational asthma caused by a hardener containing an aliphatic and a cycloaliphatic diamine. Am Rev Respir Dis 1992;145:1217-8.
47. Beasley R, Roche WR, Roberts JA, Holgate ST. Cellular events in the bronchi in mild asthma and after bronchial provocation. Am Rev Respir Dis 1989;139:806-17.
48. Bentley AM, Meng Q, Robinson DS, Hamid Q, Kay AB, Durham SR. Increases in activated T lymphocytes, eosinophils, and cytokine mRNA expression for interleukin-5 and granulocyte-macrophage colony-stimulating factor in bronchial biopsies after allergen challenge in atopic asthmatics. Am J Respir Cell Mol Biol 1993;8:35-42.
49. Pin I, Freitag AP, O'Byrne P, Girgis-Gabardo A, Watson RM, Dolovich J, Denburg JA, Hargreave FE. Changes in the cellular profile of induced sputum after allergen-induced asthmatic responses. Am Rev Respir Dis 1992;145:1265-9.
50. Broide DH, Gleich GJ, Cuomo AJ, Coburn DA, Federman EC, Schwartz LB, Wasserman SI. Evidence of ongoing mast cell and eosinophil degranulation in symptomatic asthma airway. J Allergy Clin Immunol 1991;88:637-48.
51. Laitinen LA, Laitinen A, Heino M, Haathela T. Eosinophilic inflammation during exacerbation of asthma and its treatment with inhaled corticosteroid. Am Rev Respir Dis 1991;143:423-7.
52. Marchand F. Ein neuer Fall von Asthma bronchiale mit anatomischer Untersuchung. Dtsch Arch Klin Med 1918;127:184-209.
53. Ellis AG. The pathological anatomy of bronchial asthma. Am J Med Sci 1908;136:407-29.
54. Hogg J. Extrinsic immunologic lung disease. In: Thurlbeck WM, ed. Pathology of the Lung. New York: Thieme Medical Publishers, 1988: 577-90.
55. Filley WV, Holley KE, Kephart GM, Gleich GJ. Identification of immunofluorescence of eosinophil granule major basic protein in lung tissues of patients with bronchial asthma. Lancet 1982;2:11-6.
56. Azzawi M, Johnston PW, Majumdar S, Kay AB, Jefferey PK. T lymphocytes and activated eosinophils in airway mucosa in fatal asthma and cystic fibrosis. Am Rev Respir Dis 1992;145:1477-82.
57. Adelroth E, Rosenhall L, Johansson S, Linden M, Venge P. Inflammatory cells and eosinophilic activity in asthmatics investigated by bronchoalveolar lavage: the effects of antiasthmatic treatment with budesonide or terbutaline. Am Rev Respir Dis 1990;142:91-9.
58. Burke C, Power CK, Norris A, Condez A, Schmekel B, Poulter LW. Lung function and immunopathological changes after inhaled corticosteroid therapy in asthma. Eur Respir J 1992;5:73-9.
59. Djukanovic R, Wilson JW, Britten KM et al. Effect of an inhaled corticosteroid on airway inflammation and symptoms in asthma. Am Rev Respir Dis 1992;145:669-74.
60. Jeffery PK, Godfrey RW, Adelroth E, Nelson F, Rogers A, Johansson S-A. Effect of treatment of airway inflammation and thickening of basement membrane reticular collagen in asthma: a quantitative light and electron microscopic study. Am Rev Respir Dis 1992;145:890-9.
61. Laitinen LA, Laitinen A, Haahtela T. A comparative study of the effects of an inhaled corticosteroid, budesonide, and a β2-agonist, terbutaline, on airway inflammation in newly diagnosed asthma: a randomized, double-blind parallel group controlled trial. J Allergy Clin Immunol 1992;89:32-42.
62. Lundgren R, Soderberg M, Hörstedt P, Stenling R. Morphological studies of bronchial mucosal biopsies before and after ten years of treatment with inhaled steroids. Eur Respir J 1988;1:883-9.
63. Redier H, Chanez P, De Vos C, Rifai N, Clauzel AM, Michel FB, Godard P. Inhibitory effect of cetirizine on the bronchial eosinophil recruitment induced by allergen inhalation challenge in allergic patients with asthma. J Allergy Clin Immunol 1992;90:215-24.
64. Saetta M, Maestrelli P, Di Steffano A, De Marzo N, Milani GF, Pivirotto F, Mapp CE, Fabrri LM. Effect of cessation of exposure to toluene diiscocyanate (TDI) on bronchial mucosa of subjects with TDI-induced asthma. Am Rev Respir Dis 1992;145:169-74.
65. Lacoste JL, Bousquet J, Chanez P, Vie P, Enander I, Godard P, Michel FB. Eosinophilic and neutrophilic inflammation in chronic bronchitis and chronic obstructive lung diseases. J Allergy Clin Immunol 1993;92:537-48.
66. Allen JN, Davis WB, Pacht ER. Diagnostic significance of increased bronchoalveolar lavage fluid eosinophils. Am Rev Respir Dis 1990;142: 642-7.
67. Costabel U, Teschler H, Guzman J. Bronchiolitis obliterans organizing pneumonia (BOOP): the cytological and immunocytological profile of bronchoalveolar lavage. Eur Respir J 1992;5:791-7.
68. Schwartz DA, Galvin JR, Merchant RK, Dayton CS, Burmeister LF, Merchant JA, Hunninghake GW. Influence of cigarette smoking on bronchoalveolar lavage cellularity in asbestos-induced lung disease. Am Rev Respir Dis 1992;145:400-5.
69. Weller PF, Rand TH, Goelz SE, Chi-Rosso G, Lobb RR. Human eosinophil adherence to vascular endothelium mediated by binding to vascular cell adhesion molecule 1 and endothelium leukocyte adhesion molecule 1. Proc Natl Acad Sci USA 1991;88:7530-3.
70. Hansel TT, Walker C. The migration of eosinophils into sputum of asthmatics: the role of adhesion molecules. Clin Exp Allergy 1992;22: 345-56.
71. Bochner BS, Luscinskas FW, Gimbrone MA, Newman W, Sterbinsky SA, Derse-Anthony CP, Klunk D, Schleimer RP. Adhesion of human basophils, eosinophils, and neutrophils to interleukin-1 activated human vascular endothelial cells: contributions of endothelial cell adhesion molecules. J Exp Med 1991;173:1553-6.
72. Berman JS, Weller PF. Airway eosinophils and lymphocytes in asthma. Am Rev Respir Dis 1992;145:1246-8.
73. Weller PF. Cytokine regulation of eosinophil function. Clin Immunol Immunopathol 1992;62:S55-9.
74. Takatsu K. Interleukin 5 and its receptor. Microbiol Immunol 1991;35: 593-606.
75. Warringa RAJ, Schweizer RC, Maikoe T, Kuijper PHM, Bruijnzeel PLB, Koenderman L. Modulation of eosinophil chemotaxis by interleukin-5. Am J Respir Cell Mol Biol 1992;7:631-6.
76. Robinson DS. Interleukin-5, eosinophils and bronchial hyperreactivity. Clin Exp Allergy 1993;23:1-3.
77. Kita H, Weiler DA, Abu-Ghazaleh R, Sanderson CJ, Gleich GJ. Chemotaxis of eosinophils cultured with IL-5. J Immunol 1992;149:629-35.
78. Wallen N, Kita H, Weiler D, Gleich GJ. Glucocorticoids inhibit cytokine-mediated eosinophil survival. J Immunol 1991;147:3490-5.
79. Lamas AM, Leon OG, Schleimer RP. Glucocorticoids inhibit eosinophil responses to granulocyte-macrophage colony-stimulating factor. J Immunol 1991;147:254-9.
80. Hamid Q, Azzawi M, Ying S, Moqbel R, Wardlaw AJ, Corrigan CJ, Bradley B, Durham SR, Collins JV, Jeffery PK, Quint DJ, Kay AB. Expression of mRNA for interleukin-5 in mucosal bronchial biopsies from asthma. J Clin Invest 1991;87:1541-6.
81. Robinson DS, Hamid Q, Ying S, et al. Predominant Th2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med 1992; 326:298-304.
82. Walker C, Bode E, Boer L, Hansel T, Blaser K, Virchow JC Jr. Allergic and nonallergic asthmatics have distinct patterns of T-cell activation and cytokine production in peripheral blood and bronchoalveolar lavage. Am Rev Respir Dis 1992;146:109-15.
83. Corrigan CJ, Kay AB. T cells and eosinophils in the pathogenesis of asthma. Immunol Today 1992;13:501-6.
84. Walker C, Virchow JC, Bruijnzeel PLB, Blaser KT. T cell subsets and their soluble products regulate eosinophilia in allergic and non-allergic asthma. J Immunol 1991;146:1829-35.
85. Robinson DS, Bentley AM, Hartnell A, Kay AB, Durhma SR. Activated memory T helper cells in bronchoalveolar lavage fluid from patients with atopic asthma: relation to asthma symptoms, lung function, and bronchial responsiveness. Thorax 1993;48:26-32.
86. Broide DH, Firestein GS. Endobronchial allergen-challenge in asthma. Demonstration of cellular source of granulocyte-macrophage colony-stimulating factor by in situ hybridization. J Clin Invest 1991;88:1048-53.
87. Kita K, Ohnishe T, Okubo Y, Weiler D, Abrams JS, Gleich GJ. GM-CSF and IL-3 release from human peripheral blood eosinophils and neutrophils. J Exp Med 1991;174:745-8.
88. Moqbel R, Hamid Q, Ying S, Barkans J, Hartnell A, Tsicopoulos A, Wardlaw AJ, Kay AB. Expression of mRNA and immunoreactivity for the granulocyte/macrophage colony-stimulating factor in activated human eosinophils. J Exp Med 1991;174:749-52.
89. Desrumeaux P, Janin A, Colombel JF, Prin L, Plumas J, Emilie D, Torpier G, Capron A, Capron M. Interleukin 5 messenger RNA expression by eosinophils in the intestinal mucosa of patients with coeliac disease. J Exp Med 1992;175:293-6.
90. Broide DH, Paine MM, Firestein GS. Eosinophils express interleukin 5 and granulocyte macrophage-colony stimulating factor mRNA at sites of allergic inflammation in asthmatics. J Clin Invest 1992;90:1414-24.
91. Bradding P, Feather IH, Howarth PH, Mueller R, Roberts JA, Britten K, Bews JPA, Hunt TC, Okayama Y, Heusser CH, Bullock GR, Church MK, Holgate ST. Interleukin 4 is localized and released by human mast cells. J Exp Med 1992;176:1381-6.
92. Weller PF. The immunobiology of eosinophils. N Engl J Med 1991;324:1110-8.
93. Dahl R, Venge P, Fredens K. The eosinophil. In: Barnes PJ, Rodger I, Thomson N, eds. Asthma: Basic Mechanisms and Clinical Management. London: Academic Press, 1988:115-31.
94. Capron M, Eosinophils: receptors and mediators in hypersensitivity. Clin Exp Allergy 1989;19(suppl 1):3-8.
95. Venge P, Hakansson L, Peterson CGB. Eosinophil activation in allergic disease. Int Arch Allergy Appl Immun 1987;82:333-8.
96. Olsson I, Venge P, Spitznagel JK, Lehrer RI. Arginine-rich cationic proteins of human eosinophil granules: comparison of the constituents of eosinophilic and neutrophilic leukocytes. Lab Invest 1977;36: 493-500.
97. Gleich GJ, Loegering DA, Mann KG, Maldonado JE. Comparative properties of the Charcot-Leyden crystal protein and the major basic protein from human eosinophil. J Clin Invest 1976;57:633-40.
98. Venge D, Dahl R, Fredens K, Peterson CGB. Epithelial injury by human eosinophils. Am Rev Respir Dis 1988;138:S54-7.
99. Frigas E, Loegering DA, Gleich GJ. Cytotoxic effects of the guinea pig eosinophil major basic protein in tracheal epithelium. Lab Invest 1980; 42:35-43.
100. Hastie AT, Loegering DA, Gleich GJ, Kueppers F. The effect of purified human eosinophil major basic protein on mammalian ciliary activity. Am Rev Respir Dis 1987;135:848-56.
101. Gleich GJ, Frigas E, Loegering A, Wasson DL, Steinmuller D. Cytotoxic properties of the eosinophil major basic protein. J Immunol 1970; 123:2925-37.
102. Robinson BWS, Venaille T, Blum R, Mendis AHW. Eosinophils and major basic protein damage but do not detach human amniotic epithelial cells. Exp Lung Res 1992;18:583-93.
103. Davies RJ, Oilier S, Cundell DR. Drug treatment for nasal allergy. Clin Exp Allergy 1989;19:559-68.
104. Demoly P, Crampette L, Mondain M, Lequeux N, Schwartz LB, Guerrier B, Michel FB, Bousquet J. Inflammation in non-infectious chronic sinusitis by immunohistochemistry. J Allergy Clin Immunol 1993;91:265.
105. Flavahan NA, Slifman NR, Gleich DJ, Van Houtte PM. Human eosinophil major basic protein causes hyperreactivity of respiratory smooth muscle: role of the epithelium. Am Rev Respir Dis 1988;138:685-8.